Ignite Creation Date:
2025-12-24 @ 9:14 PM
Ignite Modification Date:
2026-01-22 @ 12:33 PM
Study NCT ID:
NCT02169804
Status:
COMPLETED
Last Update Posted:
2014-10-01
First Post:
2014-06-16
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
Sponsor:
Repros Therapeutics Inc.
Organization:
Study Overview
Official Title:
An Open-Label Study to Evaluate the Effect of Age Upon the Pharmacokinetics of Androxal
Status:
COMPLETED
Status Verified Date:
2014-09
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
• To determine and compare the pharmacokinetics (PK) of 3 doses of 25 mg Androxal in elderly healthy adult male subjects.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: